AmirAli Talasaz - 21 Aug 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Aug 2026, 17:21:34 UTC
Prior SEC filing
12 Aug 2026
Next SEC filing
02 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz

Key filing fact

AmirAli Talasaz filed Form 4 for Guardant Health, Inc. (GH) on 24 Aug 2026.

Key facts

  • This page summarizes AmirAli Talasaz's Form 4 filing for Guardant Health, Inc. (GH).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Aug 2026, 17:21.

Change

  • Previous filing in this sequence was filed on 12 Aug 2026.
  • Current net transaction value: -$6,343,384.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001753159 Primary reporting owner

Talasaz AmirAli

Relationship
Co-Chief Executive Officer, Director
Address
3100 HANOVER STREET, PALO ALTO
Signature
/s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz
Signature date
24 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

Common Stock

Sale

Transaction value
$1,517,631
Shares
-9,023
Change %
-12%
Price
$168.20
Shares after
65,977
Date
21 Aug 2026
Ownership
Shares held by the Talasaz Family Foundation
Footnotes
F1
GH transaction

Common Stock

Sale

Transaction value
$3,533,452
Shares
-20,888
Change %
-32%
Price
$169.16
Shares after
45,089
Date
21 Aug 2026
Ownership
Shares held by the Talasaz Family Foundation
Footnotes
F2
GH transaction

Common Stock

Sale

Transaction value
$1,292,302
Shares
-7,589
Change %
-17%
Price
$170.29
Shares after
37,500
Date
21 Aug 2026
Ownership
Shares held by the Talasaz Family Foundation
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $167.81 to $168.60. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F2

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $168.87 to $169.73. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F3

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $169.88 to $170.50. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .